|
PARD3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.278100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.117200E-01 |
| Normal-vs-Stage2 |
2.936100E-03 |
| Normal-vs-Stage3 |
3.094400E-01 |
| Normal-vs-Stage4 |
2.078000E-01 |
| Stage1-vs-Stage2 |
4.095900E-02 |
| Stage1-vs-Stage3 |
6.739600E-01 |
| Stage1-vs-Stage4 |
9.219600E-01 |
| Stage2-vs-Stage3 |
2.380100E-02 |
| Stage2-vs-Stage4 |
9.720400E-02 |
| Stage3-vs-Stage4 |
6.872400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.238420E-01 |
| Normal-vs-AfricanAmerican |
4.402400E-01 |
| Normal-vs-Asian |
4.692400E-01 |
| Caucasian-vs-AfricanAmerican |
1.501810E-01 |
| Caucasian-vs-Asian |
8.154000E-01 |
| AfricanAmerican-vs-Asian |
2.296200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.006300E-02 |
| Normal-vs-Female |
1.129220E-01 |
| Male-vs-Female |
3.808200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.560400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.011790E-01 |
| Normal-vs-Age(61-80Yrs) |
4.042100E-02 |
| Normal-vs-Age(81-100Yrs) |
1.631970E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.154200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.922400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.357000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.025000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.569400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.401600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.197400E-01 |
| Classical-VS-Follicular |
2.16340279024507E-11 |
| Classical-VS-Other |
2.560600E-01 |
| Classical-VS-Normal |
8.438000E-01 |
| Tall-VS-Follicular |
2.55520000047582E-07 |
| Tall-VS-Other |
1.063780E-01 |
| Tall-VS-Normal |
4.703800E-01 |
| Follicular-VS-Other |
2.600200E-01 |
| Follicular-VS-Normal |
5.51259999870268E-08 |
| Other-VS-Normal |
1.601200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.975900E-04 |
| Normal-vs-N1 |
2.433200E-01 |
| N0-vs-N1 |
1.830620E-01 |
|
|
